|
|
 News Archive
Latest article: |
|
|
Recent articles: |
|
OGT Launches New ISCA-Endorsed CytoSure™ aCGH Arrays for Detecting Disease and Syndrome-Related Aberrations
03 Feb 2010: Oxford Gene Technology (OGT) has introduced three new CytoSure™ ISCA aCGH arrays to meet all resolution, multiplexing and budget requirements. Designed in collaboration with the International Standard Cytogenomic Array (ISCA) Consortium, they provide powerful arrays focusing on disease and syndrome-associated genome regions, in addition to offering whole genome coverage.
Oxford Gene Technology Ltd
|
New, Improved Cytogenetics Arrays from OGT
12 Nov 2008: Oxford Gene Technology (OGT), the pioneer of microarray-based technologies, has launched the latest versions of its CytoSure™ family of high resolution oligonucleotide arrays, offering even more coverage than before for cytogenetic syndromes and accurate whole genome aberration detection. The Syndrome Plus v2 and Chromosome X High Density arrays have been developed in close collaboration with leading cytogeneticists for a complete, cost-effective array solution.
Oxford Gene Technology Ltd
|
Oxford Gene Technology Launches CytoSure Products for the Cytogenetics Research Community
06 Jul 2007: Oxford Gene Technology (OGT) announces the launch of two array CGH (aCGH) products designed exclusively for the cytogenetics research community. Branded under the family name CytoSure™, Syndrome Plus and Chromosome X exon specific arrays will debut at the European Cytogenetics Association conference in Istanbul, 7th-10th July, 2007.
Oxford Gene Technology Ltd
|
Oxford Gene Technology in collaboration with the Wellcome Trust Sanger Institute to develop a microarray to test for genetic defects in unborn children
31 Jan 2007: Oxford Gene Technology (OGT) and the Wellcome Trust Sanger Institute are pleased to announce the signing of a collaboration agreement to develop a single platform microarray to test for genetic defects in unborn children.
Oxford Gene Technology Ltd
|
Oxford Gene Technology in collaboration with St George’s, University of London and St George’s Healthcare NHS Trust to develop diagnostic chip to test for multiple sexually transmitted infections
13 Dec 2006: Oxford Gene Technology (OGT), St George’s University of London and St George’s Healthcare NHS Trust are pleased to announce the signing of a collaboration agreement to develop a cost-effective single platform microarray to diagnose multiple sexually transmitted infections (STIs).
Oxford Gene Technology Ltd
|
Oxford Gene Technology Joins CHAVI Funded Project to Provide Microarrays for HIV Vaccine Research
05 Dec 2006: Oxford Gene Technology (OGT) is pleased to announce that it has been selected to design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology (CHAVI) research project to develop vaccines for HIV.
Oxford Gene Technology Ltd
|
|
|
|
|
|
|
 |
|
|
|
blood transfusion
